UnitedHealth Group Incorporated (NYSE:UNH)
UnitedHealth Group Incorporated (NYSE:UNH) represented a move of 0.74 percent or $-0.65 per share and closed its previous day trading session at $276.65. 3.8 Million Shares were traded in the last trading session with an Average Volume of 2.97 Million Shares. The stock currently has a Market Capitalization of 266.19 Billion.
UnitedHealthcare Group Inc. is dedicated to helping people nationwide live healthier lives by simplifying the health care experience, meeting consumer health and wellness needs and sustaining trusted relationships with care providers. The company offers the full spectrum of health benefit programs for individuals, employers, military service members, retirees and their families, and Medicare and Medicaid beneficiaries, and contracts directly with the physicians and care professionals, and hospitals and other care facilities nationwide.
The stock traded between $208.48 and $278.00 over 1-Year time period showing its price to sales ratio of 1.21. UnitedHealth Group Incorporated (NYSE:UNH) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $4.42 and 200-Day Simple Moving Average of $12.07. Its Price to Free Cash Flow is 25.07 and Price to Book of 5.51.
Analyst’s recommended the stock as 1.6 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, UnitedHealth Group Incorporated (NYSE:UNH) reported its Actual EPS of $3.41/share. The analysts offering Earnings Estimates for the company were believing that UnitedHealth Group Incorporated could bring EPS of $3.29/share. The difference between Actual EPS and Estimated EPS was 0.12 Percent. Thus showing an Earnings Surprise of 3.6 Percent.
TherapeuticsMD, Inc. (NASDAQ:TXMD)
In the last trading session, TherapeuticsMD, Inc. (NASDAQ:TXMD) added its value by 6.42% closing at the price of $4.97. The stock currently has market capitalization of 1.15 Billion, with average volume of 2.79 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently TherapeuticsMD, Inc. (NASDAQ:TXMD) is showing beta of 1.33. This particular value of beta suggests that TherapeuticsMD, Inc. (NASDAQ:TXMD) has historically moved 133% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for TherapeuticsMD, Inc. (NASDAQ:TXMD) is at $-0.44.
The stock currently has RSI of 42.4. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.
TherapeuticsMD, Inc. (NASDAQ:TXMD) topped its 52-week high price of $7.66 on 06/08/18 and 52-Week Low Price of $4.30 on 10/30/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 6.41% and monthly volatility of 7.17% respectively.